Effect of FK506 on the interleukin 15-driven proliferation and apoptosis of anti-CD3-activated umbilical cord blood T cells

Annals of Allergy, Asthma and Immunology

Volumn 95, Issue 6, 2005, Pages 586-592

  Lin, Syh Jae ^a   Yan, Dah Chin ^a   Kuo, Ming Ling ^b   Cheng, Po Jen ^c   Hsiao, Shiu Shan ^a   Tsai, Tien Lung ^d  

^a CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d NATIONAL PINGTUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD3 ANTIBODY; FAS ANTIGEN; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; TACROLIMUS;

ADULT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE PROLIFERATION; NEWBORN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; UMBILICAL CORD BLOOD;

EID: 29444436788     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61023-X     Document Type: Article

References (27)

1. Rocha V, Sanz G, Gluckman E; Eurocord and European Blood and Marrow Transplant Group. Umbilical cord blood transplantation. Curr Opin Hematol. 2004;11:375-385.
2. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med. 1998;339:1565-1577.
3. Bogunia-Kubik K, Perez-Gruz I, Fallen PR, Madrigal JA, Cohen SBA. Cord blood (CB) lymphocytes have a low frequency of cytokine producing T cells due to a high threshold for activation. Immunol Lett. 2000;72:145-146.
4. Suen Y, Lee SM, Qian J, et al. Dysregulation of lymphokine production in the neonate and its impact on neonatal cell mediated immunity. Vaccine. 1998;16:1369-1377.
5. + T cells. Eur J Haematol. 2003;71:425-432.
6. Kadereit S, Kozik MM, Junge GR, et al. Cyclosporin A effects during primary and secondary activation of human umbilical cord blood T lymphocytes. Exp Hematol. 2001;29:903-909.
7. McDouall RM, Suitters AJ, Smith H, et al. Increased cyclosporine sensitivity of T cells from cord blood compared with those from the adult. Clin Exp Immunol. 1994;95:519-524.
8. Letko E, Bhol K, Pinar V, Foster CS, Ahmed AR. Tacrolimus (FK 506). Ann Allergy Asthma Immunol. 1999;83:179-189.
9. Strauss G, Osen W, Debatin KM. Induction of apoptosis and modulation of activation and effector function in T cells by immunosuppressive drugs. Clin Exp Immunol. 2001;128:255-266.
10. Budd RC. Activation-induced cell death. Curr Opin Immunol. 2001;13:356-362.
11. Hashimoto Y, Matsuoka N, Kawakami A, et al. Novel immunosuppressive effect of FK506 by augmentation of T cell apoptosis. Clin Exp Immunol. 2001;125:19-24.
12. Vathsala A, Chin YM, Noraiza I, Sun L. Inhibition of apoptosis in anti-CD3-treated peripheral blood lymphocytes by immunosuppressive drugs. Transplant Proc. 2000;32:1992-1994.
13. Carson WE, Giri JG, Lindemann MJ, et al. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med. 1994;180:1395-1403.
14. Rutella S, Pierelli L, Bonanno G, et al. Immune reconstitution after autologous peripheral blood progenitor cell transplantation: effect of interleukin-15 on T-cell survival and effector functions. Exp Hematol. 2001;29:1503-1516.
15. Alpdogan O, Eng JM, Muriglan SJ, et al. Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation. Blood. 2005;105:865-873.
16. Chik KW, Li K, Pong H, et al. Elevated serum interleukin-15 level in acute graft-versus-host disease after hematopoietic cell transplantation. J Pediatr Hematol Oncol. 2003;25:960-964.
17. Sakata N, Yasui M, Okamura T, et al. Kinetics of plasma cytokines after hematopoietic stem cell transplantation from unrelated donors: the ratio of plasma IL-10/sTNFR level as a potential prognostic marker in severe acute graft-versus-host disease. Bone Marrow Transplant. 2001;27:1153-1161.
18. Neter J, Kutner MH, Nachtsheim CJ, Wasserman W. Two-factor experiments with repeated measures on both factors. In: Neter J, Kutner MH, Nachtsheim CJ, Wasserman W, eds. Applied Linear Statistical Models. New York, NY: McGraw-Hill Co; 1996:1176-1184.
19. Alileche A, Goldman CK, Waldmann TA. Differential effects of IL-2 and IL-15 on expression of IL-2 receptor α. Biochem Biophys Res Commun. 2001;285:1302-1308.
20. Campbell JD, Cook G, Robertson SE, et al. Suppression of IL-2-induced T cell proliferation and phosphorylation of STAT3 and STAT5 by tumor-derived TGFβ is reversed by IL-15. J Immunol. 2001;167:553-561.
21. Migita K, Eguchi K, Kawabe Y, et al. FK506 augments activation-induced programmed cell death of T lymphocytes in vivo. J Clin Invest. 1995;96:727-732.
22. Waldmann TA, Dubois S, Tagay Y. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. Immunity. 2001;14:105-110.
23. Lenardo M, Chan KM, Hornung F, et al. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol. 1999;17:221-253.
24. Kung JT, Beller D, Ju ST. Lympholike regulation of activation-induced apoptosis in T cells of IL-2 and IL-2Rβ knockout mice. Cell Immunol. 1998;185:158-163.
25. Smolewska E, Brozik H, Smolewski P, et al. Apoptosis of peripheral blood lymphocytes in patients with juvenile idiopathic arthritis. Ann Rheum Dis. 2003;62:761-763.
26. Lynch DH, Ramsdell F, Alderson MR. Fas and FasL in homeostatic regulation of immune responses. Immunol Today. 1995;16:569-574.
27. Maekawa Y, Tsukumo S, Okada H, et al. Breakdown of peripheral tolerance by chronic interleukin-15 elevation. Transplantation. 2003;76:415-420.